A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Name: A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment
Published: 2012
License: Public Domain

Janssen Infectious Diseases BVBA · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

hepatitis-c pharmacokinetics safety

hepatic impairment, hepatitis c, telaprevir, vx-950, pharmacokinetics, safety, unbound plasma concentrations, child-pugh score, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Related documents